Veterinary Vaccine Adjuvants Market By Adjuvant Type (Aluminum Salts, Oil Emulsion (Oil in Water, Water in Oil, Etc.), Polymer Dispersions, Saponins, Others); By Route of Administration (Oral, Injectable, Mucosal, Others); By Animal Type (Poultry, Fishes, Swine, Cattle and Small Ruminants, Pets and Horses, Others); By End Use (Commercial Manufacturing, Research); By Region (Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific); Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe); North America (U.S., Canada, Mexico, Rest Of North America); - Asia Pacific, Europe & North America Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Animal vaccines are among the most essential substance used as a medium to control and prevent infectious diseases. In the process of development of animal vaccines, the selection of an appropriate adjuvant is an important step. Adjuvants used in vaccines aid in improving the immune response of animals to vaccines. The outcome obtained through the application of specific adjuvants are varied. They include an overall stronger immune response, longer duration of immunity to the vaccine, an earlier onset of immunity and a specific type of immunity. In order to effectively stimulate an appropriate immune response, specific criteria including animal species and their sensitivity, the type of disease, route of administration and the type of antigen (live or inactivated) amongst other aspects are required to be considered.
Vaccine adjuvants are primarily microbial components, chemicals or mammalian proteins. The prevalent concern pertaining to limited efficacy and available therapeutic options for veterinary has garnered increased impetus on vaccine, thereby driving the growth of Asia Pacific, Europe & North America veterinary vaccine adjuvants market. Favourable government initiatives towards distribution of vaccines is estimated to boost the growth of veterinary vaccine adjuvants market over the period of next right years. World Organisation for Animal Health (OIE), for instance, are pioneering the development of vaccine banks, to ensure procurement of high quality vaccines, which are manufactured in compliance with OIE intergovernmental standards, and their timely delivery. Until February 2021, two vaccine banks focusing on Peste des Petits Ruminants (PPR) and Rabies have been established.
In terms of revenue, global veterinary vaccine adjuvants market was valued at US$ 326.33 Mn in 2020 growing at a CAGR of 5.9% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Asia Pacific, Europe & North America Veterinary Vaccine Adjuvants Market Revenue & Forecast, (US$ Million), 2015 – 2029
Adjuvant Type Outlook:
On the basis of ajuvant type, Asia Pacific, Europe & North America veterinary vaccine adjuvants market is classified into aluminum salts, oil emulsion (oil in water, water in oil, etc.), polymer dispersions and saponins amongst others. Aluminum is the most popularly used vaccines adjuvants and is found in some of the most common animal vaccines including tetanus, diphtheria, whooping cough (DTP) vaccine and also vaccines which protect against HPV, anthrax, hepatitis A and hepatitis B amongst others. The segment held the highest share in the veterinary vaccine adjuvants market in 2020.
Route of Administration Outlook:
Based on route of administration, Asia Pacific, Europe & North America veterinary vaccine adjuvants market is segmented on the basis of oral, injectable, mucosal and others. Injectable route of administration accounted for the highest market share in 2020. Selecting the route of administration is extremely essential and largely defines the level of efficacy on selected animal species. The mucosal route of administration, however, is estimated to register highest growth rate over the forecast period.
Animal Type Outlook:
On the basis of animal type, Asia Pacific, Europe & North America veterinary vaccine adjuvants market is classified into poultry, fishes, swine, cattle and small ruminants, pets and horses and others. Cattle and small ruminants held the highest market share and were also responsible in generating highest share of revenues for major market participants in the region. Vaccine adjuvants have a significant impact on stimulating the immune systems of cattle and small ruminants. Seppic, for instance, provides Montanide adjuvants, which are used in vaccines for cattle and small ruminants. These vaccines address parasitic, viral and bacterial diseases including coronavirus, foot and mouth disease (FMD), haemorrhagic septicaemia, E. Coli, rotavirus and clostridium botilunum in these species.
End Use Outlook:
Based on end use, Asia Pacific, Europe & North America veterinary vaccine adjuvants market is bifurcated into commercial manufacturing and research. Veterinary vaccine adjuvants have registered maximum applications in the field of research. A substantial investment by pharmaceutical companies, academic institutions and research institutes are being directed towards research activities. Veterinary vaccine adjuvants market participants are specifically focusing on products for clinical trials and research activities. Avanti Polar Lipids, which is a part of Croda International Plc., provide adjuvants complying with cGMP guidelines in bulk quantities, which support clinical trial activities of the end users.
Region Outlook:
North America held the largest share in the Asia Pacific, Europe & North America veterinary vaccine adjuvants market in 2020. The presence of established vendors in the region encompassing a large market share, developed countries exhibiting exhaustive research and development facilities along with substantial investments being driven towards research and development activities are contributing towards the region’s highest share in the market.
Competitive Landscape Outlook:
The report provides both, qualitative and quantitative research of Asia Pacific, Europe & North America veterinary vaccine adjuvants market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the Asia Pacific, Europe & North America veterinary vaccine adjuvants market are Bioveta, a.s., Croda International Pl, Merck & Co., Inc., Phibro Animal Health Corporation, SEPPIC, SPI Pharma, and Zoetis amongst other market participants.
Asia Pacific, Europe & North America Veterinary Vaccine Adjuvants Market:
By Adjuvant Type:
- Aluminum Salts
- Oil Emulsion (Oil in Water, Water in Oil, Etc.)
- Polymer Dispersions
- Saponins
- Others
By Route of Administration:
- Oral
- Injectable
- Mucosal
- Others
By Animal Type:
- Poultry
- Fishes
- Swine
- Cattle and Small Ruminants
- Pets and Horses
- Others
By End Use:
- Commercial Manufacturing
- Research
By Region:
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- North America
- U.S
- Canada
- Mexico
- Rest of North America
Table of Contents
Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2019
1.2.2. Base Year: 2020
1.2.3. Forecast Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Asia Pacific, Europe & North America Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Veterinary Vaccine Adjuvants Market
6. Market Synopsis:
Veterinary Vaccine Adjuvants Market
7. Veterinary Vaccine Adjuvants Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Veterinary Vaccine Adjuvants Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators: Veterinary
Vaccine Adjuvants Market
7.6. Porter’s Five Force Analysis
8. Asia Pacific Veterinary Vaccine Adjuvants Market Analysis and
Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$
Mn)
8.2. Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Adjuvant Type
8.2.1. Aluminum Salts
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2020
8.2.1.3. Market Forecast, 2021 - 2029
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. China
8.2.1.5.1.1. Market
Estimation, 2015 - 2020
8.2.1.5.1.2. Market
Forecast, 2021 - 2029
8.2.1.5.2. Japan
8.2.1.5.2.1. Market
Estimation, 2015 - 2020
8.2.1.5.2.2. Market
Forecast, 2021 - 2029
8.2.1.5.3. India
8.2.1.5.3.1. Market
Estimation, 2015 - 2020
8.2.1.5.3.2. Market
Forecast, 2021 - 2029
8.2.1.5.4. New Zealand
8.2.1.5.4.1. Market
Estimation, 2015 - 2020
8.2.1.5.4.2. Market
Forecast, 2021 - 2029
8.2.1.5.5. Australia
8.2.1.5.5.1. Market
Estimation, 2015 - 2020
8.2.1.5.5.2. Market
Forecast, 2021 - 2029
8.2.1.5.6. South Korea
8.2.1.5.6.1. Market
Estimation, 2015 - 2020
8.2.1.5.6.2. Market
Forecast, 2021 - 2029
8.2.1.5.7. Southeast Asia
8.2.1.5.7.1. Market
Estimation, 2015 - 2020
8.2.1.5.7.2. Market
Forecast, 2021 - 2029
8.2.1.5.8. Rest of Asia Pacific
8.2.1.5.8.1. Market
Estimation, 2015 - 2020
8.2.1.5.8.2. Market
Forecast, 2021 - 2029
8.2.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. China
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Japan
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. India
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. New Zealand
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Australia
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.2.2.5.6. South Korea
8.2.2.5.6.1. Market
Estimation, 2015 - 2020
8.2.2.5.6.2. Market
Forecast, 2021 - 2029
8.2.2.5.7. Southeast Asia
8.2.2.5.7.1. Market
Estimation, 2015 - 2020
8.2.2.5.7.2. Market
Forecast, 2021 - 2029
8.2.2.5.8. Rest of Asia Pacific
8.2.2.5.8.1. Market
Estimation, 2015 - 2020
8.2.2.5.8.2. Market
Forecast, 2021 - 2029
8.2.3. Polymer Dispersions
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2020
8.2.3.3. Market Forecast, 2021 - 2029
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. China
8.2.3.5.1.1. Market
Estimation, 2015 - 2020
8.2.3.5.1.2. Market
Forecast, 2021 - 2029
8.2.3.5.2. Japan
8.2.3.5.2.1. Market
Estimation, 2015 - 2020
8.2.3.5.2.2. Market
Forecast, 2021 - 2029
8.2.3.5.3. India
8.2.3.5.3.1. Market
Estimation, 2015 - 2020
8.2.3.5.3.2. Market
Forecast, 2021 - 2029
8.2.3.5.4. New Zealand
8.2.3.5.4.1. Market
Estimation, 2015 - 2020
8.2.3.5.4.2. Market
Forecast, 2021 - 2029
8.2.3.5.5. Australia
8.2.3.5.5.1. Market
Estimation, 2015 - 2020
8.2.3.5.5.2. Market
Forecast, 2021 - 2029
8.2.3.5.6. South Korea
8.2.3.5.6.1. Market
Estimation, 2015 - 2020
8.2.3.5.6.2. Market
Forecast, 2021 - 2029
8.2.3.5.7. Southeast Asia
8.2.3.5.7.1. Market
Estimation, 2015 - 2020
8.2.3.5.7.2. Market
Forecast, 2021 - 2029
8.2.3.5.8. Rest of Asia Pacific
8.2.3.5.8.1. Market
Estimation, 2015 - 2020
8.2.3.5.8.2. Market
Forecast, 2021 - 2029
8.2.4. Saponins
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2020
8.2.4.3. Market Forecast, 2021 - 2029
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. China
8.2.4.5.1.1. Market
Estimation, 2015 - 2020
8.2.4.5.1.2. Market
Forecast, 2021 - 2029
8.2.4.5.2. Japan
8.2.4.5.2.1. Market
Estimation, 2015 - 2020
8.2.4.5.2.2. Market
Forecast, 2021 - 2029
8.2.4.5.3. India
8.2.4.5.3.1. Market
Estimation, 2015 - 2020
8.2.4.5.3.2. Market
Forecast, 2021 - 2029
8.2.4.5.4. New Zealand
8.2.4.5.4.1. Market
Estimation, 2015 - 2020
8.2.4.5.4.2. Market
Forecast, 2021 - 2029
8.2.4.5.5. Australia
8.2.4.5.5.1. Market
Estimation, 2015 - 2020
8.2.4.5.5.2. Market
Forecast, 2021 - 2029
8.2.4.5.6. South Korea
8.2.4.5.6.1. Market
Estimation, 2015 - 2020
8.2.4.5.6.2. Market
Forecast, 2021 - 2029
8.2.4.5.7. Southeast Asia
8.2.4.5.7.1. Market
Estimation, 2015 - 2020
8.2.4.5.7.2. Market
Forecast, 2021 - 2029
8.2.4.5.8. Rest of Asia Pacific
8.2.4.5.8.1. Market
Estimation, 2015 - 2020
8.2.4.5.8.2. Market
Forecast, 2021 - 2029
8.2.5. Others
8.2.5.1. Definition
8.2.5.2. Market Estimation and Penetration, 2015 - 2020
8.2.5.3. Market Forecast, 2021 - 2029
8.2.5.4. Compound Annual Growth Rate (CAGR)
8.2.5.5. Regional Bifurcation
8.2.5.5.1. China
8.2.5.5.1.1. Market
Estimation, 2015 - 2020
8.2.5.5.1.2. Market
Forecast, 2021 - 2029
8.2.5.5.2. Japan
8.2.5.5.2.1. Market
Estimation, 2015 - 2020
8.2.5.5.2.2. Market
Forecast, 2021 - 2029
8.2.5.5.3. India
8.2.5.5.3.1. Market
Estimation, 2015 - 2020
8.2.5.5.3.2. Market
Forecast, 2021 - 2029
8.2.5.5.4. New Zealand
8.2.5.5.4.1. Market
Estimation, 2015 - 2020
8.2.5.5.4.2. Market
Forecast, 2021 - 2029
8.2.5.5.5. Australia
8.2.5.5.5.1. Market
Estimation, 2015 - 2020
8.2.5.5.5.2. Market
Forecast, 2021 - 2029
8.2.5.5.6. South Korea
8.2.5.5.6.1. Market
Estimation, 2015 - 2020
8.2.5.5.6.2. Market
Forecast, 2021 - 2029
8.2.5.5.7. Southeast Asia
8.2.5.5.7.1. Market
Estimation, 2015 - 2020
8.2.5.5.7.2. Market
Forecast, 2021 - 2029
8.2.5.5.8. Rest of Asia Pacific
8.2.5.5.8.1. Market
Estimation, 2015 - 2020
8.2.5.5.8.2. Market
Forecast, 2021 - 2029
8.3. Key Segment for Channeling Investments
8.3.1. By Adjuvant Type
9. Asia Pacific Veterinary Vaccine Adjuvants Market Analysis and
Forecasts, 2021 – 2029
9.1. Overview
9.2. Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Route of Administration
9.2.1. Oral
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2020
9.2.1.3. Market Forecast, 2021 - 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. China
9.2.1.5.1.1. Market
Estimation, 2015 - 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Japan
9.2.1.5.2.1. Market
Estimation, 2015 - 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. India
9.2.1.5.3.1. Market
Estimation, 2015 - 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. New Zealand
9.2.1.5.4.1. Market
Estimation, 2015 - 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Australia
9.2.1.5.5.1. Market
Estimation, 2015 - 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.1.5.6. South Korea
9.2.1.5.6.1. Market
Estimation, 2015 - 2020
9.2.1.5.6.2. Market
Forecast, 2021 - 2029
9.2.1.5.7. Southeast Asia
9.2.1.5.7.1. Market
Estimation, 2015 - 2020
9.2.1.5.7.2. Market
Forecast, 2021 - 2029
9.2.1.5.8. Rest of Asia Pacific
9.2.1.5.8.1. Market
Estimation, 2015 - 2020
9.2.1.5.8.2. Market
Forecast, 2021 - 2029
9.2.2. Injectable
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. China
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Japan
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. India
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. New Zealand
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Australia
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.2.2.5.6. South Korea
9.2.2.5.6.1. Market
Estimation, 2015 - 2020
9.2.2.5.6.2. Market
Forecast, 2021 - 2029
9.2.2.5.7. Southeast Asia
9.2.2.5.7.1. Market
Estimation, 2015 - 2020
9.2.2.5.7.2. Market
Forecast, 2021 - 2029
9.2.2.5.8. Rest of Asia Pacific
9.2.2.5.8.1. Market
Estimation, 2015 - 2020
9.2.2.5.8.2. Market
Forecast, 2021 - 2029
9.2.3. Mucosal
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2020
9.2.3.3. Market Forecast, 2021 - 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. China
9.2.3.5.1.1. Market
Estimation, 2015 - 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Japan
9.2.3.5.2.1. Market
Estimation, 2015 - 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. India
9.2.3.5.3.1. Market
Estimation, 2015 - 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. New Zealand
9.2.3.5.4.1. Market
Estimation, 2015 - 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Australia
9.2.3.5.5.1. Market
Estimation, 2015 - 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.2.3.5.6. South Korea
9.2.3.5.6.1. Market
Estimation, 2015 - 2020
9.2.3.5.6.2. Market
Forecast, 2021 - 2029
9.2.3.5.7. Southeast Asia
9.2.3.5.7.1. Market
Estimation, 2015 - 2020
9.2.3.5.7.2. Market
Forecast, 2021 - 2029
9.2.3.5.8. Rest of Asia Pacific
9.2.3.5.8.1. Market
Estimation, 2015 - 2020
9.2.3.5.8.2. Market
Forecast, 2021 - 2029
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2020
9.2.4.3. Market Forecast, 2021 - 2029
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. China
9.2.4.5.1.1. Market
Estimation, 2015 - 2020
9.2.4.5.1.2. Market
Forecast, 2021 - 2029
9.2.4.5.2. Japan
9.2.4.5.2.1. Market
Estimation, 2015 - 2020
9.2.4.5.2.2. Market
Forecast, 2021 - 2029
9.2.4.5.3. India
9.2.4.5.3.1. Market
Estimation, 2015 - 2020
9.2.4.5.3.2. Market
Forecast, 2021 - 2029
9.2.4.5.4. New Zealand
9.2.4.5.4.1. Market
Estimation, 2015 - 2020
9.2.4.5.4.2. Market
Forecast, 2021 - 2029
9.2.4.5.5. Australia
9.2.4.5.5.1. Market
Estimation, 2015 - 2020
9.2.4.5.5.2. Market
Forecast, 2021 - 2029
9.2.4.5.6. South Korea
9.2.4.5.6.1. Market
Estimation, 2015 - 2020
9.2.4.5.6.2. Market
Forecast, 2021 - 2029
9.2.4.5.7. Southeast Asia
9.2.4.5.7.1. Market
Estimation, 2015 - 2020
9.2.4.5.7.2. Market
Forecast, 2021 - 2029
9.2.4.5.8. Rest of Asia Pacific
9.2.4.5.8.1. Market
Estimation, 2015 - 2020
9.2.4.5.8.2. Market
Forecast, 2021 - 2029
9.3. Key Segment for Channeling Investments
9.3.1. By Route of Administration
10. Asia Pacific Veterinary Vaccine Adjuvants Market Analysis and
Forecasts, 2021 – 2029
10.1. Overview
10.2. Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Animal Type
10.2.1. Poultry
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. China
10.2.1.5.1.1. Market
Estimation, 2015 - 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Japan
10.2.1.5.2.1. Market
Estimation, 2015 - 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. India
10.2.1.5.3.1. Market
Estimation, 2015 - 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. New Zealand
10.2.1.5.4.1. Market
Estimation, 2015 - 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Australia
10.2.1.5.5.1. Market
Estimation, 2015 - 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.1.5.6. South Korea
10.2.1.5.6.1. Market
Estimation, 2015 - 2020
10.2.1.5.6.2. Market
Forecast, 2021 - 2029
10.2.1.5.7. Southeast Asia
10.2.1.5.7.1. Market
Estimation, 2015 - 2020
10.2.1.5.7.2. Market
Forecast, 2021 - 2029
10.2.1.5.8. Rest of Asia Pacific
10.2.1.5.8.1. Market
Estimation, 2015 - 2020
10.2.1.5.8.2. Market
Forecast, 2021 - 2029
10.2.2. Fishes
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. China
10.2.2.5.1.1. Market
Estimation, 2015 - 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Japan
10.2.2.5.2.1. Market
Estimation, 2015 - 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. India
10.2.2.5.3.1. Market
Estimation, 2015 - 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. New Zealand
10.2.2.5.4.1. Market
Estimation, 2015 - 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Australia
10.2.2.5.5.1. Market
Estimation, 2015 - 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.2.2.5.6. South Korea
10.2.2.5.6.1. Market
Estimation, 2015 - 2020
10.2.2.5.6.2. Market
Forecast, 2021 - 2029
10.2.2.5.7. Southeast Asia
10.2.2.5.7.1. Market
Estimation, 2015 - 2020
10.2.2.5.7.2. Market
Forecast, 2021 - 2029
10.2.2.5.8. Rest of Asia Pacific
10.2.2.5.8.1. Market
Estimation, 2015 - 2020
10.2.2.5.8.2. Market
Forecast, 2021 - 2029
10.2.3. Swine
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. China
10.2.3.5.1.1. Market
Estimation, 2015 - 2020
10.2.3.5.1.2. Market
Forecast, 2021 - 2029
10.2.3.5.2. Japan
10.2.3.5.2.1. Market
Estimation, 2015 - 2020
10.2.3.5.2.2. Market
Forecast, 2021 - 2029
10.2.3.5.3. India
10.2.3.5.3.1. Market
Estimation, 2015 - 2020
10.2.3.5.3.2. Market
Forecast, 2021 - 2029
10.2.3.5.4. New Zealand
10.2.3.5.4.1. Market
Estimation, 2015 - 2020
10.2.3.5.4.2. Market
Forecast, 2021 - 2029
10.2.3.5.5. Australia
10.2.3.5.5.1. Market
Estimation, 2015 - 2020
10.2.3.5.5.2. Market
Forecast, 2021 - 2029
10.2.3.5.6. South Korea
10.2.3.5.6.1. Market
Estimation, 2015 - 2020
10.2.3.5.6.2. Market
Forecast, 2021 - 2029
10.2.3.5.7. Southeast Asia
10.2.3.5.7.1. Market
Estimation, 2015 - 2020
10.2.3.5.7.2. Market
Forecast, 2021 - 2029
10.2.3.5.8. Rest of Asia Pacific
10.2.3.5.8.1. Market
Estimation, 2015 - 2020
10.2.3.5.8.2. Market
Forecast, 2021 - 2029
10.2.4. Cattle and Small Ruminants
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2020
10.2.4.3. Market Forecast, 2021 - 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. China
10.2.4.5.1.1. Market
Estimation, 2015 - 2020
10.2.4.5.1.2. Market
Forecast, 2021 - 2029
10.2.4.5.2. Japan
10.2.4.5.2.1. Market
Estimation, 2015 - 2020
10.2.4.5.2.2. Market
Forecast, 2021 - 2029
10.2.4.5.3. India
10.2.4.5.3.1. Market
Estimation, 2015 - 2020
10.2.4.5.3.2. Market
Forecast, 2021 - 2029
10.2.4.5.4. New Zealand
10.2.4.5.4.1. Market
Estimation, 2015 - 2020
10.2.4.5.4.2. Market
Forecast, 2021 - 2029
10.2.4.5.5. Australia
10.2.4.5.5.1. Market
Estimation, 2015 - 2020
10.2.4.5.5.2. Market
Forecast, 2021 - 2029
10.2.4.5.6. South Korea
10.2.4.5.6.1. Market
Estimation, 2015 - 2020
10.2.4.5.6.2. Market
Forecast, 2021 - 2029
10.2.4.5.7. Southeast Asia
10.2.4.5.7.1. Market
Estimation, 2015 - 2020
10.2.4.5.7.2. Market
Forecast, 2021 - 2029
10.2.4.5.8. Rest of Asia Pacific
10.2.4.5.8.1. Market
Estimation, 2015 - 2020
10.2.4.5.8.2. Market
Forecast, 2021 - 2029
10.2.5. Pets and Horses
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2020
10.2.5.3. Market Forecast, 2021 - 2029
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. China
10.2.5.5.1.1. Market
Estimation, 2015 - 2020
10.2.5.5.1.2. Market
Forecast, 2021 - 2029
10.2.5.5.2. Japan
10.2.5.5.2.1. Market
Estimation, 2015 - 2020
10.2.5.5.2.2. Market
Forecast, 2021 - 2029
10.2.5.5.3. India
10.2.5.5.3.1. Market
Estimation, 2015 - 2020
10.2.5.5.3.2. Market
Forecast, 2021 - 2029
10.2.5.5.4. New Zealand
10.2.5.5.4.1. Market
Estimation, 2015 - 2020
10.2.5.5.4.2. Market
Forecast, 2021 - 2029
10.2.5.5.5. Australia
10.2.5.5.5.1. Market
Estimation, 2015 - 2020
10.2.5.5.5.2. Market
Forecast, 2021 - 2029
10.2.5.5.6. South Korea
10.2.5.5.6.1. Market
Estimation, 2015 - 2020
10.2.5.5.6.2. Market
Forecast, 2021 - 2029
10.2.5.5.7. Southeast Asia
10.2.5.5.7.1. Market
Estimation, 2015 - 2020
10.2.5.5.7.2. Market
Forecast, 2021 - 2029
10.2.5.5.8. Rest of Asia Pacific
10.2.5.5.8.1. Market
Estimation, 2015 - 2020
10.2.5.5.8.2. Market
Forecast, 2021 - 2029
10.2.6. Others
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 - 2020
10.2.6.3. Market Forecast, 2021 - 2029
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. China
10.2.6.5.1.1. Market
Estimation, 2015 - 2020
10.2.6.5.1.2. Market
Forecast, 2021 - 2029
10.2.6.5.2. Japan
10.2.6.5.2.1. Market
Estimation, 2015 - 2020
10.2.6.5.2.2. Market
Forecast, 2021 - 2029
10.2.6.5.3. India
10.2.6.5.3.1. Market
Estimation, 2015 - 2020
10.2.6.5.3.2. Market
Forecast, 2021 - 2029
10.2.6.5.4. New Zealand
10.2.6.5.4.1. Market
Estimation, 2015 - 2020
10.2.6.5.4.2. Market
Forecast, 2021 - 2029
10.2.6.5.5. Australia
10.2.6.5.5.1. Market
Estimation, 2015 - 2020
10.2.6.5.5.2. Market
Forecast, 2021 - 2029
10.2.6.5.6. South Korea
10.2.6.5.6.1. Market
Estimation, 2015 - 2020
10.2.6.5.6.2. Market
Forecast, 2021 - 2029
10.2.6.5.7. Southeast Asia
10.2.6.5.7.1. Market
Estimation, 2015 - 2020
10.2.6.5.7.2. Market
Forecast, 2021 - 2029
10.2.6.5.8. Rest of Asia Pacific
10.2.6.5.8.1. Market
Estimation, 2015 - 2020
10.2.6.5.8.2. Market
Forecast, 2021 - 2029
10.3. Key Segment for Channeling Investments
10.3.1. By Animal Type
11. Asia Pacific Veterinary Vaccine Adjuvants Market Analysis and
Forecasts, 2021 – 2029
11.1. Overview
11.2. Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By End Use
11.2.1. Commercial Manufacturing
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2020
11.2.1.3. Market Forecast, 2021 - 2029
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. China
11.2.1.5.1.1. Market
Estimation, 2015 - 2020
11.2.1.5.1.2. Market
Forecast, 2021 - 2029
11.2.1.5.2. Japan
11.2.1.5.2.1. Market
Estimation, 2015 - 2020
11.2.1.5.2.2. Market
Forecast, 2021 - 2029
11.2.1.5.3. India
11.2.1.5.3.1. Market
Estimation, 2015 - 2020
11.2.1.5.3.2. Market
Forecast, 2021 - 2029
11.2.1.5.4. New Zealand
11.2.1.5.4.1. Market
Estimation, 2015 - 2020
11.2.1.5.4.2. Market
Forecast, 2021 - 2029
11.2.1.5.5. Australia
11.2.1.5.5.1. Market
Estimation, 2015 - 2020
11.2.1.5.5.2. Market
Forecast, 2021 - 2029
11.2.1.5.6. South Korea
11.2.1.5.6.1. Market
Estimation, 2015 - 2020
11.2.1.5.6.2. Market
Forecast, 2021 - 2029
11.2.1.5.7. Southeast Asia
11.2.1.5.7.1. Market
Estimation, 2015 - 2020
11.2.1.5.7.2. Market
Forecast, 2021 - 2029
11.2.1.5.8. Rest of Asia Pacific
11.2.1.5.8.1. Market
Estimation, 2015 - 2020
11.2.1.5.8.2. Market
Forecast, 2021 - 2029
11.2.2. Research
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2020
11.2.2.3. Market Forecast, 2021 - 2029
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. China
11.2.2.5.1.1. Market
Estimation, 2015 - 2020
11.2.2.5.1.2. Market
Forecast, 2021 - 2029
11.2.2.5.2. Japan
11.2.2.5.2.1. Market
Estimation, 2015 - 2020
11.2.2.5.2.2. Market
Forecast, 2021 - 2029
11.2.2.5.3. India
11.2.2.5.3.1. Market
Estimation, 2015 - 2020
11.2.2.5.3.2. Market
Forecast, 2021 - 2029
11.2.2.5.4. New Zealand
11.2.2.5.4.1. Market
Estimation, 2015 - 2020
11.2.2.5.4.2. Market
Forecast, 2021 - 2029
11.2.2.5.5. Australia
11.2.2.5.5.1. Market
Estimation, 2015 - 2020
11.2.2.5.5.2. Market
Forecast, 2021 - 2029
11.2.2.5.6. South Korea
11.2.2.5.6.1. Market
Estimation, 2015 - 2020
11.2.2.5.6.2. Market
Forecast, 2021 - 2029
11.2.2.5.7. Southeast Asia
11.2.2.5.7.1. Market
Estimation, 2015 - 2020
11.2.2.5.7.2. Market
Forecast, 2021 - 2029
11.2.2.5.8. Rest of Asia Pacific
11.2.2.5.8.1. Market
Estimation, 2015 - 2020
11.2.2.5.8.2. Market
Forecast, 2021 - 2029
11.3. Key Segment for Channeling Investments
11.3.1. By End Use
12. Asia Pacific Veterinary Vaccine Adjuvants Market Analysis and
Forecasts, 2021 - 2029
12.1. Overview
12.2. Asia Pacific Veterinary Vaccine Adjuvants Market Revenue (US$
Mn), By Country
12.2.1. China
12.2.1.1. China Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Adjuvant Type
12.2.1.1.1. Aluminum Salts
12.2.1.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
12.2.1.1.3. Polymer Dispersions
12.2.1.1.4. Saponins
12.2.1.1.5. Others
12.2.1.2. China Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Route of Administration
12.2.1.2.1. Oral
12.2.1.2.2. Injectable
12.2.1.2.3. Mucosal
12.2.1.2.4. Others
12.2.1.3. China Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Animal Type
12.2.1.3.1. Poultry
12.2.1.3.2. Fishes
12.2.1.3.3. Swine
12.2.1.3.4. Cattle and Small Ruminants
12.2.1.3.5. Pets and Horses
12.2.1.3.6. Others
12.2.1.4. China Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By End Use
12.2.1.4.1. Commercial Manufacturing
12.2.1.4.2. Research
12.2.2. Japan
12.2.2.1. Japan Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Adjuvant Type
12.2.2.1.1. Aluminum Salts
12.2.2.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
12.2.2.1.3. Polymer Dispersions
12.2.2.1.4. Saponins
12.2.2.1.5. Others
12.2.2.2. Japan Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Route of Administration
12.2.2.2.1. Oral
12.2.2.2.2. Injectable
12.2.2.2.3. Mucosal
12.2.2.2.4. Others
12.2.2.3. Japan Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Animal Type
12.2.2.3.1. Poultry
12.2.2.3.2. Fishes
12.2.2.3.3. Swine
12.2.2.3.4. Cattle and Small Ruminants
12.2.2.3.5. Pets and Horses
12.2.2.3.6. Others
12.2.2.4. Japan Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By End Use
12.2.2.4.1. Commercial Manufacturing
12.2.2.4.2. Research
12.2.3. India
12.2.3.1. India Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Adjuvant Type
12.2.3.1.1. Aluminum Salts
12.2.3.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
12.2.3.1.3. Polymer Dispersions
12.2.3.1.4. Saponins
12.2.3.1.5. Others
12.2.3.2. India Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Route of Administration
12.2.3.2.1. Oral
12.2.3.2.2. Injectable
12.2.3.2.3. Mucosal
12.2.3.2.4. Others
12.2.3.3. India Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Animal Type
12.2.3.3.1. Poultry
12.2.3.3.2. Fishes
12.2.3.3.3. Swine
12.2.3.3.4. Cattle and Small Ruminants
12.2.3.3.5. Pets and Horses
12.2.3.3.6. Others
12.2.3.4. India Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By End Use
12.2.3.4.1. Commercial Manufacturing
12.2.3.4.2. Research
12.2.4. New Zealand
12.2.4.1. New Zealand Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Adjuvant Type
12.2.4.1.1. Aluminum Salts
12.2.4.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
12.2.4.1.3. Polymer Dispersions
12.2.4.1.4. Saponins
12.2.4.1.5. Others
12.2.4.2. New Zealand Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Route of Administration
12.2.4.2.1. Oral
12.2.4.2.2. Injectable
12.2.4.2.3. Mucosal
12.2.4.2.4. Others
12.2.4.3. New Zealand Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Animal Type
12.2.4.3.1. Poultry
12.2.4.3.2. Fishes
12.2.4.3.3. Swine
12.2.4.3.4. Cattle and Small Ruminants
12.2.4.3.5. Pets and Horses
12.2.4.3.6. Others
12.2.4.4. New Zealand Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By End Use
12.2.4.4.1. Commercial Manufacturing
12.2.4.4.2. Research
12.2.5. Australia
12.2.5.1. Australia Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Adjuvant Type
12.2.5.1.1. Aluminum Salts
12.2.5.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
12.2.5.1.3. Polymer Dispersions
12.2.5.1.4. Saponins
12.2.5.1.5. Others
12.2.5.2. Australia Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Route of Administration
12.2.5.2.1. Oral
12.2.5.2.2. Injectable
12.2.5.2.3. Mucosal
12.2.5.2.4. Others
12.2.5.3. Australia Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Animal Type
12.2.5.3.1. Poultry
12.2.5.3.2. Fishes
12.2.5.3.3. Swine
12.2.5.3.4. Cattle and Small Ruminants
12.2.5.3.5. Pets and Horses
12.2.5.3.6. Others
12.2.5.4. Australia Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By End Use
12.2.5.4.1. Commercial Manufacturing
12.2.5.4.2. Research
12.2.6. South Korea
12.2.6.1. South Korea Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Adjuvant Type
12.2.6.1.1. Aluminum Salts
12.2.6.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
12.2.6.1.3. Polymer Dispersions
12.2.6.1.4. Saponins
12.2.6.1.5. Others
12.2.6.2. South Korea Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Route of Administration
12.2.6.2.1. Oral
12.2.6.2.2. Injectable
12.2.6.2.3. Mucosal
12.2.6.2.4. Others
12.2.6.3. South Korea Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Animal Type
12.2.6.3.1. Poultry
12.2.6.3.2. Fishes
12.2.6.3.3. Swine
12.2.6.3.4. Cattle and Small Ruminants
12.2.6.3.5. Pets and Horses
12.2.6.3.6. Others
12.2.6.4. South Korea Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By End Use
12.2.6.4.1. Commercial Manufacturing
12.2.6.4.2. Research
12.2.7. Southeast Asia
12.2.7.1. Southeast Asia Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Adjuvant Type
12.2.7.1.1. Aluminum Salts
12.2.7.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
12.2.7.1.3. Polymer Dispersions
12.2.7.1.4. Saponins
12.2.7.1.5. Others
12.2.7.2. Southeast Asia Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Route of Administration
12.2.7.2.1. Oral
12.2.7.2.2. Injectable
12.2.7.2.3. Mucosal
12.2.7.2.4. Others
12.2.7.3. Southeast Asia Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Animal Type
12.2.7.3.1. Poultry
12.2.7.3.2. Fishes
12.2.7.3.3. Swine
12.2.7.3.4. Cattle and Small Ruminants
12.2.7.3.5. Pets and Horses
12.2.7.3.6. Others
12.2.7.4. Southeast Asia Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By End Use
12.2.7.4.1. Commercial Manufacturing
12.2.7.4.2. Research
12.2.7.5. Southeast Asia Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Country
12.2.7.5.1. Indonesia
12.2.7.5.2. Thailand
12.2.7.5.3. Malaysia
12.2.7.5.4. Singapore
12.2.7.5.5. Rest of Southeast Asia
12.2.8. Rest of Asia Pacific
12.2.8.1. Rest of Asia Pacific Veterinary Vaccine Adjuvants Market
Revenue (US$ Mn) and Forecasts, By Adjuvant Type
12.2.8.1.1. Aluminum Salts
12.2.8.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
12.2.8.1.3. Polymer Dispersions
12.2.8.1.4. Saponins
12.2.8.1.5. Others
12.2.8.2. Rest of Asia Pacific Veterinary Vaccine Adjuvants Market
Revenue (US$ Mn) and Forecasts, By Route of Administration
12.2.8.2.1. Oral
12.2.8.2.2. Injectable
12.2.8.2.3. Mucosal
12.2.8.2.4. Others
12.2.8.3. Rest of Asia Pacific Veterinary Vaccine Adjuvants Market
Revenue (US$ Mn) and Forecasts, By Animal Type
12.2.8.3.1. Poultry
12.2.8.3.2. Fishes
12.2.8.3.3. Swine
12.2.8.3.4. Cattle and Small Ruminants
12.2.8.3.5. Pets and Horses
12.2.8.3.6. Others
12.2.8.4. Rest of Asia Pacific Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By End Use
12.2.8.4.1. Commercial Manufacturing
12.2.8.4.2. Research
12.3. Key Segment for Channeling Investments
12.3.1. By Country
12.3.2. By Adjuvant Type
12.3.3. By Route of Administration
12.3.4. By Animal Type
12.3.5. By End Use
13. Europe Veterinary Vaccine Adjuvants Market Analysis and Forecasts,
2021 - 2029
13.1. Overview
13.1.1. Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
13.2. Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Adjuvant Type
13.2.1. Aluminum Salts
13.2.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
13.2.3. Polymer Dispersions
13.2.4. Saponins
13.2.5. Others
13.3. Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Route of Administration
13.3.1. Oral
13.3.2. Injectable
13.3.3. Mucosal
13.3.4. Others
13.4. Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.4.1. Poultry
13.4.2. Fishes
13.4.3. Swine
13.4.4. Cattle and Small Ruminants
13.4.5. Pets and Horses
13.4.6. Others
13.5. Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By End Use
13.5.1. Commercial Manufacturing
13.5.2. Research
13.6. Europe Veterinary Vaccine Adjuvants Market Revenue (US$ Mn),
By Country
13.6.1. France
13.6.1.1. France Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Adjuvant Type
13.6.1.1.1. Aluminum Salts
13.6.1.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
13.6.1.1.3. Polymer Dispersions
13.6.1.1.4. Saponins
13.6.1.1.5. Others
13.6.1.2. France Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Route of Administration
13.6.1.2.1. Oral
13.6.1.2.2. Injectable
13.6.1.2.3. Mucosal
13.6.1.2.4. Others
13.6.1.3. France Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.6.1.3.1. Poultry
13.6.1.3.2. Fishes
13.6.1.3.3. Swine
13.6.1.3.4. Cattle and Small Ruminants
13.6.1.3.5. Pets and Horses
13.6.1.3.6. Others
13.6.1.4. France Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By End Use
13.6.1.4.1. Commercial Manufacturing
13.6.1.4.2. Research
13.6.2. The UK
13.6.2.1. The UK Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Adjuvant Type
13.6.2.1.1. Aluminum Salts
13.6.2.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
13.6.2.1.3. Polymer Dispersions
13.6.2.1.4. Saponins
13.6.2.1.5. Others
13.6.2.2. The UK Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Route of Administration
13.6.2.2.1. Oral
13.6.2.2.2. Injectable
13.6.2.2.3. Mucosal
13.6.2.2.4. Others
13.6.2.3. The UK Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.6.2.3.1. Poultry
13.6.2.3.2. Fishes
13.6.2.3.3. Swine
13.6.2.3.4. Cattle and Small Ruminants
13.6.2.3.5. Pets and Horses
13.6.2.3.6. Others
13.6.2.4. The UK Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By End Use
13.6.2.4.1. Commercial Manufacturing
13.6.2.4.2. Research
13.6.3. Spain
13.6.3.1. Spain Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Adjuvant Type
13.6.3.1.1. Aluminum Salts
13.6.3.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
13.6.3.1.3. Polymer Dispersions
13.6.3.1.4. Saponins
13.6.3.1.5. Others
13.6.3.2. Spain Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Route of Administration
13.6.3.2.1. Oral
13.6.3.2.2. Injectable
13.6.3.2.3. Mucosal
13.6.3.2.4. Others
13.6.3.3. Spain Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Animal Type
13.6.3.3.1. Poultry
13.6.3.3.2. Fishes
13.6.3.3.3. Swine
13.6.3.3.4. Cattle and Small Ruminants
13.6.3.3.5. Pets and Horses
13.6.3.3.6. Others
13.6.3.4. Spain Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By End Use
13.6.3.4.1. Commercial Manufacturing
13.6.3.4.2. Research
13.6.4. Germany
13.6.4.1. Germany Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Adjuvant Type
13.6.4.1.1. Aluminum Salts
13.6.4.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
13.6.4.1.3. Polymer Dispersions
13.6.4.1.4. Saponins
13.6.4.1.5. Others
13.6.4.2. Germany Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Route of Administration
13.6.4.2.1. Oral
13.6.4.2.2. Injectable
13.6.4.2.3. Mucosal
13.6.4.2.4. Others
13.6.4.3. Germany Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Animal Type
13.6.4.3.1. Poultry
13.6.4.3.2. Fishes
13.6.4.3.3. Swine
13.6.4.3.4. Cattle and Small Ruminants
13.6.4.3.5. Pets and Horses
13.6.4.3.6. Others
13.6.4.4. Germany Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By End Use
13.6.4.4.1. Commercial Manufacturing
13.6.4.4.2. Research
13.6.5. Italy
13.6.5.1. Italy Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Adjuvant Type
13.6.5.1.1. Aluminum Salts
13.6.5.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
13.6.5.1.3. Polymer Dispersions
13.6.5.1.4. Saponins
13.6.5.1.5. Others
13.6.5.2. Italy Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Route of Administration
13.6.5.2.1. Oral
13.6.5.2.2. Injectable
13.6.5.2.3. Mucosal
13.6.5.2.4. Others
13.6.5.3. Italy Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Animal Type
13.6.5.3.1. Poultry
13.6.5.3.2. Fishes
13.6.5.3.3. Swine
13.6.5.3.4. Cattle and Small Ruminants
13.6.5.3.5. Pets and Horses
13.6.5.3.6. Others
13.6.5.4. Italy Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By End Use
13.6.5.4.1. Commercial Manufacturing
13.6.5.4.2. Research
13.6.6. Nordic Countries
13.6.6.1. Nordic Countries Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Adjuvant Type
13.6.6.1.1. Aluminum Salts
13.6.6.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
13.6.6.1.3. Polymer Dispersions
13.6.6.1.4. Saponins
13.6.6.1.5. Others
13.6.6.2. Nordic Countries Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Route of Administration
13.6.6.2.1. Oral
13.6.6.2.2. Injectable
13.6.6.2.3. Mucosal
13.6.6.2.4. Others
13.6.6.3. Nordic Countries Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Animal Type
13.6.6.3.1. Poultry
13.6.6.3.2. Fishes
13.6.6.3.3. Swine
13.6.6.3.4. Cattle and Small Ruminants
13.6.6.3.5. Pets and Horses
13.6.6.3.6. Others
13.6.6.4. Nordic Countries Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By End Use
13.6.6.4.1. Commercial Manufacturing
13.6.6.4.2. Research
13.6.6.5. Nordic Countries Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux Union
13.6.7.1. Benelux Union Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Adjuvant Type
13.6.7.1.1. Aluminum Salts
13.6.7.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
13.6.7.1.3. Polymer Dispersions
13.6.7.1.4. Saponins
13.6.7.1.5. Others
13.6.7.2. Benelux Union Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Route of Administration
13.6.7.2.1. Oral
13.6.7.2.2. Injectable
13.6.7.2.3. Mucosal
13.6.7.2.4. Others
13.6.7.3. Benelux Union Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Animal Type
13.6.7.3.1. Poultry
13.6.7.3.2. Fishes
13.6.7.3.3. Swine
13.6.7.3.4. Cattle and Small Ruminants
13.6.7.3.5. Pets and Horses
13.6.7.3.6. Others
13.6.7.4. Benelux Union Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By End Use
13.6.7.4.1. Commercial Manufacturing
13.6.7.4.2. Research
13.6.7.5. Benelux Union Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Adjuvant Type
13.6.8.1.1. Aluminum Salts
13.6.8.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
13.6.8.1.3. Polymer Dispersions
13.6.8.1.4. Saponins
13.6.8.1.5. Others
13.6.8.2. Rest of Europe Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Route of Administration
13.6.8.2.1. Oral
13.6.8.2.2. Injectable
13.6.8.2.3. Mucosal
13.6.8.2.4. Others
13.6.8.3. Rest of Europe Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By Animal Type
13.6.8.3.1. Poultry
13.6.8.3.2. Fishes
13.6.8.3.3. Swine
13.6.8.3.4. Cattle and Small Ruminants
13.6.8.3.5. Pets and Horses
13.6.8.3.6. Others
13.6.8.4. Rest of Europe Veterinary Vaccine Adjuvants Market Revenue
(US$ Mn) and Forecasts, By End Use
13.6.8.4.1. Commercial Manufacturing
13.6.8.4.2. Research
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Adjuvant Type
13.7.3. By Route of Administration
13.7.4. By Animal Type
13.7.5. By End Use
14. North America Veterinary Vaccine Adjuvants Market Analysis
and Forecasts, 2021 - 2029
14.1. Overview
14.1.1. North America Veterinary Vaccine Adjuvants Market Revenue (US$
Mn)
14.2. North America Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Adjuvant Type
14.2.1. Aluminum Salts
14.2.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
14.2.3. Polymer Dispersions
14.2.4. Saponins
14.2.5. Others
14.3. North America Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Route of Administration
14.3.1. Oral
14.3.2. Injectable
14.3.3. Mucosal
14.3.4. Others
14.4. North America Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By Animal Type
14.4.1. Poultry
14.4.2. Fishes
14.4.3. Swine
14.4.4. Cattle and Small Ruminants
14.4.5. Pets and Horses
14.4.6. Others
14.5. North America Veterinary Vaccine Adjuvants Market Revenue (US$
Mn) and Forecasts, By End Use
14.5.1. Commercial Manufacturing
14.5.2. Research
14.6. North America Veterinary Vaccine Adjuvants Market Revenue (US$
Mn), By Country
14.6.1. U.S
14.6.1.1. U.S Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Adjuvant Type
14.6.1.1.1. Aluminum Salts
14.6.1.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
14.6.1.1.3. Polymer Dispersions
14.6.1.1.4. Saponins
14.6.1.1.5. Others
14.6.1.2. U.S Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Route of Administration
14.6.1.2.1. Oral
14.6.1.2.2. Injectable
14.6.1.2.3. Mucosal
14.6.1.2.4. Others
14.6.1.3. U.S Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By Animal Type
14.6.1.3.1. Poultry
14.6.1.3.2. Fishes
14.6.1.3.3. Swine
14.6.1.3.4. Cattle and Small Ruminants
14.6.1.3.5. Pets and Horses
14.6.1.3.6. Others
14.6.1.4. U.S Veterinary Vaccine Adjuvants Market Revenue (US$ Mn) and
Forecasts, By End Use
14.6.1.4.1. Commercial Manufacturing
14.6.1.4.2. Research
14.6.2. Canada
14.6.2.1. Canada Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Adjuvant Type
14.6.2.1.1. Aluminum Salts
14.6.2.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
14.6.2.1.3. Polymer Dispersions
14.6.2.1.4. Saponins
14.6.2.1.5. Others
14.6.2.2. Canada Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Route of Administration
14.6.2.2.1. Oral
14.6.2.2.2. Injectable
14.6.2.2.3. Mucosal
14.6.2.2.4. Others
14.6.2.3. Canada Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Animal Type
14.6.2.3.1. Poultry
14.6.2.3.2. Fishes
14.6.2.3.3. Swine
14.6.2.3.4. Cattle and Small Ruminants
14.6.2.3.5. Pets and Horses
14.6.2.3.6. Others
14.6.2.4. Canada Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By End Use
14.6.2.4.1. Commercial Manufacturing
14.6.2.4.2. Research
14.6.3. Mexico
14.6.3.1. Mexico Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Adjuvant Type
14.6.3.1.1. Aluminum Salts
14.6.3.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
14.6.3.1.3. Polymer Dispersions
14.6.3.1.4. Saponins
14.6.3.1.5. Others
14.6.3.2. Mexico Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Route of Administration
14.6.3.2.1. Oral
14.6.3.2.2. Injectable
14.6.3.2.3. Mucosal
14.6.3.2.4. Others
14.6.3.3. Mexico Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By Animal Type
14.6.3.3.1. Poultry
14.6.3.3.2. Fishes
14.6.3.3.3. Swine
14.6.3.3.4. Cattle and Small Ruminants
14.6.3.3.5. Pets and Horses
14.6.3.3.6. Others
14.6.3.4. Mexico Veterinary Vaccine Adjuvants Market Revenue (US$ Mn)
and Forecasts, By End Use
14.6.3.4.1. Commercial Manufacturing
14.6.3.4.2. Research
14.6.4. Rest of North America
14.6.4.1. Rest of North America Veterinary Vaccine Adjuvants Market
Revenue (US$ Mn) and Forecasts, By Adjuvant Type
14.6.4.1.1. Aluminum Salts
14.6.4.1.2. Oil Emulsion (Oil in Water, Water in Oil, Etc.)
14.6.4.1.3. Polymer Dispersions
14.6.4.1.4. Saponins
14.6.4.1.5. Others
14.6.4.2. Rest of North America Veterinary Vaccine Adjuvants Market
Revenue (US$ Mn) and Forecasts, By Route of Administration
14.6.4.2.1. Oral
14.6.4.2.2. Injectable
14.6.4.2.3. Mucosal
14.6.4.2.4. Others
14.6.4.3. Rest of North America Veterinary Vaccine Adjuvants Market
Revenue (US$ Mn) and Forecasts, By Animal Type
14.6.4.3.1. Poultry
14.6.4.3.2. Fishes
14.6.4.3.3. Swine
14.6.4.3.4. Cattle and Small Ruminants
14.6.4.3.5. Pets and Horses
14.6.4.3.6. Others
14.6.4.4. Rest of North America Veterinary Vaccine Adjuvants Market
Revenue (US$ Mn) and Forecasts, By End Use
14.6.4.4.1. Commercial Manufacturing
14.6.4.4.2. Research
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Adjuvant Type
14.7.3. By Route of Administration
14.7.4. By Animal Type
14.7.5. By End Use
15. Competitive Benchmarking
15.1. Market Share Analysis, 2020
15.2. Asia Pacific, Europe & North America Presence and Growth
Strategies
15.2.1. Mergers and Acquisitions
15.2.2. Product Launches
15.2.3. Investments Trends
15.2.4. R&D Initiatives
16. Player Profiles
16.1. Bioveta, a.s.
16.1.1. Company Details
16.1.2. Company Overview
16.1.3. Product Offerings
16.1.4. Key Developments
16.1.5. Financial Analysis
16.1.6. SWOT Analysis
16.1.7. Business Strategies
16.2. Croda International Pl
16.2.1. Company Details
16.2.2. Company Overview
16.2.3. Product Offerings
16.2.4. Key Developments
16.2.5. Financial Analysis
16.2.6. SWOT Analysis
16.2.7. Business Strategies
16.3. Merck & Co., Inc.
16.3.1. Company Details
16.3.2. Company Overview
16.3.3. Product Offerings
16.3.4. Key Developments
16.3.5. Financial Analysis
16.3.6. SWOT Analysis
16.3.7. Business Strategies
16.4. Phibro Animal Health Corporation
16.4.1. Company Details
16.4.2. Company Overview
16.4.3. Product Offerings
16.4.4. Key Developments
16.4.5. Financial Analysis
16.4.6. SWOT Analysis
16.4.7. Business Strategies
16.5. SEPPIC
16.5.1. Company Details
16.5.2. Company Overview
16.5.3. Product Offerings
16.5.4. Key Developments
16.5.5. Financial Analysis
16.5.6. SWOT Analysis
16.5.7. Business Strategies
16.6. SPI Pharma
16.6.1. Company Details
16.6.2. Company Overview
16.6.3. Product Offerings
16.6.4. Key Developments
16.6.5. Financial Analysis
16.6.6. SWOT Analysis
16.6.7. Business Strategies
16.7. Zoetis
16.7.1. Company Details
16.7.2. Company Overview
16.7.3. Product Offerings
16.7.4. Key Developments
16.7.5. Financial Analysis
16.7.6. SWOT Analysis
16.7.7. Business Strategies
16.8. Other Market Participants
17. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
